Literature DB >> 3161611

Phospholipid- and Ca2+-dependent protein kinase activity and protein phosphorylation patterns in the differentiation of human promyelocytic leukemia cell line HL-60.

E Zylber-Katz, R I Glazer.   

Abstract

The effects of differentiating agents on the activity and phosphorylation pattern produced by phospholipid- and Ca2+-dependent protein kinase (PL-Ca-PK) were examined in human promyelocytic leukemia cell line HL-60. Dimethyl sulfoxide (DMSO), retinoic acid (RA), and 1,25-dihydroxyvitamin D3 [1,25(OH)2D3] increased the appearance of mature myelocytic (DMSO and RA) or monocytic [1,25(OH)2D3] cells. The tumor promoter 12-O-tetradecanoylphorbol-13-acetate (TPA) increased the appearance of adherent macrophage-like cells. Coincident with the appearance of differentiated cells induced by DMSO, RA, and 1,25(OH)2D3 was an increase in PL-Ca-PK activity. In contrast, TPA treatment resulted in the rapid disappearance of PL-Ca-PK and the induction of phospholipid- and Ca2+- (PL-Ca-) independent protein kinase activity. The phosphorylation pattern resulting from endogenous PL-Ca-PK in extracts from cells treated with DMSO, RA, or 1,25(OH)2D3 showed a prominent phosphorylated protein of molecular weight 37,000 (pp37) and 38,000 (pp38) which was related to the appearance of the myelocyte/monocyte phenotype. pp37 and pp38 were also present in TPA-treated cells, but their phosphorylation was no longer dependent on the presence of phospholipid and calcium. Cells treated with DMSO and RA also exhibited a PL-Ca-dependent pp21 which was barely evident in 1,25(OH)2D3-treated cells and thus represented a myeloid cell marker. Also present was a prominent PL-Ca-dependent pp19 which remained unchanged following treatment with DMSO, RA, and 1,25(OH)2D3, but which diminished markedly in TPA-treated cells. On the other hand, TPA-treated cells exhibited a characteristic pp130 which was antigenically related to the actin binding protein, vinculin. These results indicate that there are characteristic PL-Ca-dependent phosphorylated proteins indicative of mature myelocytic and monocytic cells, as well as PL-Ca-independent phosphorylated proteins characteristic of the macrophage-like phenotype.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 3161611

Source DB:  PubMed          Journal:  Cancer Res        ISSN: 0008-5472            Impact factor:   12.701


  6 in total

1.  Decreased phosphorylation of a low molecular weight protein by cGMP-dependent protein kinase in variant HL-60 cells resistant to nitric oxide- and cGMP-induced differentiation.

Authors:  J S Scheele; R B Pilz; G Clark; N Gupta; D Loo; P Martis; G R Boss
Journal:  Mol Cell Biochem       Date:  1998-08       Impact factor: 3.396

2.  Induction of the 47 kDa platelet substrate of protein kinase C during differentiation of HL-60 cells.

Authors:  M Tyers; R A Rachubinski; C S Sartori; C B Harley; R J Haslam
Journal:  Biochem J       Date:  1987-04-01       Impact factor: 3.857

3.  Stimulation of synthesis de novo of NAD(+)-dependent 15-hydroxyprostaglandin dehydrogenase in human promyelocytic leukaemia (HL-60) cells by phorbol ester.

Authors:  C Q Xun; Z G Tian; H H Tai
Journal:  Biochem J       Date:  1991-10-15       Impact factor: 3.857

Review 4.  Integrating Pharmacoproteomics into Early-Phase Clinical Development: State-of-the-Art, Challenges, and Recommendations.

Authors:  Savita Nandal; Tal Burt
Journal:  Int J Mol Sci       Date:  2017-02-19       Impact factor: 5.923

5.  Ubiquitin-specific peptidase 3 induces TPA-mediated leukemia cell differentiation via regulating H2AK119ub.

Authors:  Yun-Cheol Chae; Hyeonsoo Jung; Ji-Young Kim; Dong Ho Lee; Sang-Beom Seo
Journal:  Anim Cells Syst (Seoul)       Date:  2019-09-06       Impact factor: 1.815

6.  Dimethyl Sulfoxide Suppresses Mouse 4T1 Breast Cancer Growth by Modulating Tumor-Associated Macrophage Differentiation.

Authors:  Rui Deng; Shi-Min Wang; Tao Yin; Ting-Hong Ye; Guo-Bo Shen; Ling Li; Jing-Yi Zhao; Ya-Xiong Sang; Xiao-Gang Duan; Yu-Quan Wei
Journal:  J Breast Cancer       Date:  2014-03-28       Impact factor: 3.588

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.